Wordt geladen...
Modulation of alternative splicing induced by paclitaxel in human lung cancer
Paclitaxel is utilized as the first-line chemotherapeutic regimen for the majority of advanced non-small-cell lung carcinoma. However, whether paclitaxel could suppress cancer progression through modulating RNA alternative splicing remains largely unknown. Here, we demonstrated the effects of paclit...
Bewaard in:
Gepubliceerd in: | Cell Death Dis |
---|---|
Hoofdauteurs: | , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Nature Publishing Group UK
2018
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5924756/ https://ncbi.nlm.nih.gov/pubmed/29706628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0539-4 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|